• 1.

    Ashford RW, 1979. Occurrence of an undescribed coccidian in man in Papua New Guinea. Ann Trop Med Parasitol 73: 497500.

  • 2.

    Ortega YR, Sterling CR, Gilman RH, Cama VA, Diaz F, 1993. Cyclospora species: a new protozoan pathogen of humans. N Engl J Med 328: 13081312.

  • 3.

    Ortega YR, Gilman RH, Sterling CR, 1994. A new coccidian parasite (Apicomplexa: Eimeriidae) from humans. J Parasitol 80: 625629.

  • 4.

    Ortega YR, Sanchez R, 2010. Update on Cyclospora cayetanensis, a food-borne and waterborne parasite. Clin Microbiol Rev 23: 218234.

  • 5.

    Mansfield LS, Gajadhar AA, 2004. Cyclospora cayetanensis, a food- and waterborne coccidian parasite. Vet Parasitol 126: 7390.

  • 6.

    Ortega YR, Nagle R, Gilman RH, Wateanabe J, Miyagui J, Quispe H, Kanagusuku P, Roxas C, Sterling CR, 1997. Pathologic and clinical findings in patients with cyclosporiasis and a description of intracellular parasite life-cycle stages. J Infect Dis 176: 15841589.

    • Search Google Scholar
    • Export Citation
  • 7.

    Ortega YR, Sterling CR, Gilman RH, 1998.  Cyclospora cayetanensis. Adv Parasitol 40: 399418.

  • 8.

    Nessi PA, de Gumaz RC, Wagner AC, Dorta PA, Galindo PM, Vethencourt M, de Perez GV, 2011. Reporte de cinco casos de cyclosporiosis en un centro penitenciario en Venezuela. Rev Inst Nac Hig 42: 7579.

    • Search Google Scholar
    • Export Citation
  • 9.

    Chacín-Bonilla L, Barrios F, 2011. Cyclospora cayetanensis: biología, distribución ambiental y transferencia. Biomedica 31: 132144.

  • 10.

    Vásquez TO, Jiménez DR, Campos RT, Valencia RS, Romero CR, Gamez AV, Martínez-Barbosa I, 2000. Infección por Cyclospora cayetanensis. Diagnóstico de laboratorio. Rev Latinoam Microbiol 42: 4552.

    • Search Google Scholar
    • Export Citation
  • 11.

    Verdier RI, Fitzgerald DW, Johnson WD, Pape JW, 2000. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. Ann Intern Med 132: 885888.

    • Search Google Scholar
    • Export Citation
  • 12.

    Zimmer SM, Schuetz AN, Franco-Paredes C, 2007. Efficacy of nitazoxanide for cyclosporiasis in patients with sulfa allergy. Clin Infect Dis 44: 466467.

    • Search Google Scholar
    • Export Citation
 
 
 
 

 

 
 

 

 

 

 

 

 

Cyclospora cayetanensis: This Emerging Protozoan Pathogen in Mexico

View More View Less
  • Parasitology Laboratory, Department of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico; Faculty of Chemical Sciences, Universidad Autonoma Benito Juarez de Oaxaca, Oaxaca, Mexico; LOEWE Research Group Lung Cancer Epigenetics, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany; Unidad Medica Familiar, Delegacion Sur, Unidad 21 Valle de Mexico, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Institute of Fundamental Medicine and Biology, Kazan Federal University, Tatarstan, Russia; Biochemistry Institute, Medical School, Justus-Liebig University, Giessen, Germany

A Mexican airline pilot had clinical manifestations of illness after a five-day stay in Lima, Peru. Six months later in Mexico, he was given a diagnosis of infection with Cyclospora cayetanensis by using coproparasitoscopic serial tests. He was treated twice with nitazoxadine successfully.

Author Notes

* Addrress correspondence to Héctor A. Cabrera-Fuentes or Guillermo Barreto, LOEWE Research Group Lung Cancer Epigenetic, Max-Planck-Institute for Heart and Lung Research, Parkstraβe 1, D-61231, Bad Nauheim, Germany. E-mails: guillermo.barreto@mpi-bn.mpg.de or hector.a.cabrera-fuentes@biochemie.med.uni-giessen.de† These authors contributed equally

Financial support: This study was supported by the LOEWE-Initiative der Landesförderung (III L 4 – 518/15.004 2009 to Guillermo Barreto) and the Deutsche Forschungsgemeinschaft (DFG, BA 4036/1-1 to Guillermo Barreto) H. A. Cabrera-Fuentes is member of the International Research Training Group 1566 (PROMISE) and is supported by the DFG. This work was supported in part by the Dean?s Office of the Faculty of Chemical Sciences and the Director of Strategic Planning and Evaluation at the Universidad Autonoma Benito Juarez de Oaxaca. This work was done according to the Program of competitive growth of Kazan Federal University supported by the Russian Government.

Disclosure: None of the authors has any conflicts of interest.

Authors' addresses: José T. Sánchez-Vega, Parasitology Laboratory, Department of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autonoma de Mexico, E-mail: pptrini@hotmail.com. Héctor A. Cabrera-Fuentes, Institute of Fundamental Medicine and Biology, Kazan Federal University, Tatarstan, Russia, and Biochemistry Institute, Medical School, Justus-Liebig University, Giessen, Germany, E-mail: hector.a.cabrera-fuentes@biochemie.med.uni-giessen.de. Addi J. Romero-Olmedo, Faculty of Chemical Sciences, Universidad Autonoma Benito Juarez de Oaxaca, Oaxaca, Mexico, and Lung Cancer Epigenetic, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany, E-mail: addi.romero@mpi-bn.mpg.de. José L. Ortiz-Frías, Unidad Medica Familiar, Delegacion Sur, Unidad 21 Valle de Mexico, Instituto Mexicano del Seguro Social, Mexico City, Mexico, E-mail: joseortizfrias@yahoo.com.mx. Sokolina Flura, Institute of Fundamental Medicine and Biology, Kazan Federal University, Tatarstan, Russia, E-mail: flura.sokolina@kpfu.ru. Guillermo Barreto, LOEWE Research Group Lung Cancer Epigenetic, Max-Planck-Institute for Heart, and Lung Research, Bad Nauheim, Germany, E-mail: guillermo.barreto@mpi-bn.mpg.de.

Save